Loading ETF profile…
The VanEck Pharmaceutical ETF (PPH) endeavors to match, before any charges or costs, the price and income returns of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR) as precisely as feasible. This benchmark is constructed to reflect the comprehensive performance of businesses operating within the pharmaceutical sector, covering their activities from drug discovery and development to manufacturing, promotion, and distribution.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| LLY | Eli Lilly & Co | 19.38% | $178.59M |
| NVS | Novartis Ag | 10.79% | $99.46M |
| MRK | Merck & Co Inc | 9.51% | $87.64M |
| NVO | Novo Nordisk A/S | 5.51% | $50.76M |
| PFE | Pfizer Inc | 4.80% | $44.25M |
| GSK | Gsk Plc | 4.55% | $41.97M |
| BMY | Bristol-Myers Squibb Co | 4.47% | $41.19M |
| ABBV | Abbvie Inc | 4.43% | $40.82M |
| MCK | Mckesson Corp | 4.33% | $39.86M |
| AZN | Astrazeneca Plc | 4.29% | $39.56M |
| JNJ | Johnson & Johnson | 4.25% | $39.21M |
| SNY | Sanofi Sa/France | 4.05% | $37.34M |
| COR | Cencora Inc | 3.46% | $31.88M |
| TEVA | Teva Pharmaceutical Industries Ltd | 3.11% | $28.67M |
| HLN | Haleon Plc | 3.08% | $28.36M |
| TAK | Takeda Pharmaceutical Co Ltd | 2.95% | $27.14M |
| ZTS | Zoetis Inc | 2.33% | $21.46M |
| VTRS | Viatris Inc | 1.13% | $10.39M |
| JAZZ | Jazz Pharmaceuticals Plc | 1.07% | $9.88M |
| AXSM | Axsome Therapeutics Inc | 0.79% | $7.26M |
| CORT | Corcept Therapeutics Inc | 0.48% | $4.43M |
| ELAN | Elanco Animal Health Inc | 0.35% | $3.18M |
| — | Other/Cash | 0.31% | $2.86M |
| OGN | Organon & Co | 0.24% | $2.18M |
| — | -USD CASH- | 0.19% | $1.75M |